Octreotide (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Octreotide drug offered from Fresenius Kabi USA, LLC. This Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
| NON-PROPRIETARY NAME: | OCTREOTIDE ACETATE |
| SUBSTANCE NAME: | OCTREOTIDE ACETATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] |
| ROUTE: | INTRAVENOUS; SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2006-03-14 |
| END MARKETING DATE: | 0000-00-00 |
Octreotide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Octreotide from Fresenius Kabi USA, LLC |
| LABELER NAME: | Fresenius Kabi USA, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(ug/mL) |
| START MARKETING DATE: | 2006-03-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63323-365_b2cc3858-5461-4b02-a0ca-559853c3471f |
| PRODUCT NDC: | 63323-365 |
| APPLICATION NUMBER: | ANDA077457 |
Other OCTREOTIDE ACETATE Pharmaceutical Manufacturers / Labelers:
